期刊文献+

硫辛酸对早期2型糖尿病肾病尿微量白蛋白的影响 被引量:4

下载PDF
导出
摘要 目的研究硫辛酸对早期2型糖尿病肾病患者24 h尿微量白蛋白的影响。方法选择56例早期2型糖尿病肾病患者,随机分为两组,各28例。对照组常规给予胰岛素控制血糖、降压、降血脂等药物治疗,硫辛酸组在对照组基础上给予硫辛酸。测定治疗前后24 h尿微量白蛋白水平。结果治疗后硫辛酸组较对照组24 h尿微量白蛋白明显下降(P<0.05)。结论硫辛酸可降低早期2型糖尿病肾病患者24 h尿微量白蛋白,对肾脏有保护作用。
出处 《河南医学研究》 CAS 2015年第3期53-54,共2页 Henan Medical Research
  • 相关文献

参考文献8

  • 1Ding Y,Choi M E.Autophagy in diabetic nephropathy[J].J Endocrinol,2015,224(1):R15-R30.
  • 2Bhatti F,Mankhey R W,Asico L,et al.Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney[J].Kidney Int,2005,67(4):1371-1380.
  • 3颜新凤,冯波,徐雷,薛俊丽.α-硫辛酸对2型糖尿病大鼠肾脏显微和超微组织结构的影响[J].中国实用内科杂志,2007,27(23):1846-1848. 被引量:17
  • 4孙士鹤,刘尚清.糖尿病肾病发病机制研究概况[J].中国医药,2012,7(1):118-120. 被引量:17
  • 5Brownlee M.The pathobiology of diabetic complications,a unifying mechanism[J].Diabetes,2005,54(6):1615.
  • 6Balkis-Budin S,Othman F,Louis S R,et al.Effect of alphalipoic acid on oxidative stress and vascular wall of diabetic rats[J].Rom J Morphol Embryol,2009,50(1):23-30.
  • 7Noori N,Tabibi H,Hosseinpanah F,et al.Effects of combined lipoic acid and pyridoxine on albuminuria,advanced glycation end-products,and blood pressure in diabetic nephropathy[J].Int J Vitam Nutr Res.2013,83(2):77-85.
  • 8张春阳,邹俊杰,石勇铨,夏凌,王怀清,曲卫,刘志民.α-硫辛酸减轻糖尿病大鼠肾脏损伤的机制[J].中华内分泌代谢杂志,2010,26(1):60-62. 被引量:11

二级参考文献45

  • 1Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001,414 : 813 -820.
  • 2Melhem MF,Craven PA, Liaehenko J, et al. a-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soe Nephrol,2002,13 : 108-116.
  • 3Umezono T, Toyoda M, Kato M, et al. Glomerular expression of CTGF, TGF-beta I and type IV collagen in diabetic nephropathy. J Nephrol, 2006,19:751-757.
  • 4Singh R, Song RH, Alavi N, et al. High glucose decreases matrix metalloproteinase activity in rat mesangial cells via transforming growth factor β1. Exp Nephrol,2001,9 :249-257.
  • 5Ziyadeh FN. Mediators of diabetic renal disease :the case for TGF-β as the major mediator. J Am Soe Nephrol,2004,15:S55-S57.
  • 6Ziyadeh FN, Hoffman BB, Han DC, et al. Long term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA,2000,97:8015-8020.
  • 7Schrijvers BF,Flyvbjerg A,De Vriese AS.The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.Kidney Int,2004,65 (6):2003-2017.
  • 8Locatelli F,Canaud B,Eckardt KU,et al.The importance of diabetic nephropathy in current nephrological practice.Nephrol Dial Transplant,2003,18 (9):1716-1725.
  • 9Ceriello A.New insights on oxidative stress and diabetic complications may lead to a " causal" antioxidant therapy.Diabetes Care,2003,26(5):1589-1596.
  • 10Barati MT,Merchant ML,Kain AB,et al.Proteomic analysis defines altered cellular redox pathways and advanced glycation endproduct metabolism in glomeruli ofdb/db diabetic mice.Am J Physiol Renal Physiol,2007,293(4):F1157-F1165.

共引文献41

同被引文献28

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部